Wang, H., Su, X., Yang, M., Chen, T., Hou, J., Li, N., & Cao, X. (2015). Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma. Oncoimmunology.
Chicago Style CitationWang, Huamin, Xiaoping Su, Mingjin Yang, Taoyong Chen, Jin Hou, Nan Li, and Xuetao Cao. "Reciprocal Control of MiR-197 and IL-6/STAT3 Pathway Reveals MiR-197 As Potential Therapeutic Target for Hepatocellular Carcinoma." Oncoimmunology 2015.
MLA CitationWang, Huamin, et al. "Reciprocal Control of MiR-197 and IL-6/STAT3 Pathway Reveals MiR-197 As Potential Therapeutic Target for Hepatocellular Carcinoma." Oncoimmunology 2015.
Warning: These citations may not always be 100% accurate.